10000 news items
Page 10 of 100
s113xu0zszf0a7xn2h6wey ihuiwocyj11
ALOT
19 Jun 24
on Form 10-K for the fiscal year ended January 31, 2024 and subsequent filings AstroNova makes with the Securities and Exchange Commission. The Company
ktw4qnj2 kslbii8qz
AAWH
19 Jun 24
on Form 10-K for the year ended December 31, 2023, and in the Company's other reports
t3sed9417olfma9xmt9q7brgjievsn1wcfwnlewgymimr9gi
AAWH
19 Jun 24
information and statements herein. Such factors include, among others, the risks and uncertainties identified in the Company's Annual Report on Form 10-K
b3gt0iop7afbnxz6ke2yzo7m2qmxzgq1p142pmrux
FTAI
19 Jun 24
Discussion and Analysis of Financial Condition and Results of Operations" in the Company's most recent Annual Report on Form 10-K and Quarterly Reports
sb6q0heivicbjqqy63ceit4 xvkicx0c8574
GTBIF
19 Jun 24
most recent Annual Report on Form 10-K. Investor Contact:Andy GrossmanEVP, Capital Markets & Investor
328rmgmob9 ivu4s2yof6w9
NEM
WRN
19 Jun 24
.(2) See Newmont Corporation Form 10-K: Annual report for the year ending December 31, 2023, in the Measured, Indicated, and Inferred
qv19fvvejaqhtw v38q2qvlw5xgzz5lgorq16zee22heagvk4gn16
MGM
19 Jun 24
in existing and new jurisdictions, and additional risks and uncertainties described in MGM Resorts International's Form 10-K, Form 10-Q and Form 8-K
6c4jdektu2df o91g9q0p69jqu4czlf2tymlqxkuh6dcc3vd3w
NUTX
19 Jun 24
that can affect future results are discussed in the Annual Report on Form 10-K for the year ended
q637pxl98rzjaq743m
ACN
19 Jun 24
as the risks, uncertainties and other factors discussed under the "Risk Factors" heading in Accenture plc's most recent Annual Report on Form 10-K and other
wreij9o950p3jbbofk56ppbp5hub27lm7n4pmy
GL
18 Jun 24
Inc. f/k/a Torchmark Corporation (NYSE:GL), if they purchased or otherwise
y1h8riiy57aq6ifp4gz08mz70y5vn7q8n8o46i3ro8a8cy 5qvfbiv89oj
OPT
18 Jun 24
Offer to raise approximately A$55.0m (US$36.9m1) will close at 5:00 pm (Melbourne time) on 10 July 2024
wnn zmjvci9gp85qlrtexpea358
BOH
18 Jun 24
about these factors is contained in the Company's Annual Report on Form 10-K for the year ended December 31, 2023 and its form 10-Q for the fiscal
cljtb4id2s3z6ar
ABBV
18 Jun 24
is set forth in Item 1A, "Risk Factors," of AbbVie's 2023 Annual Report on Form 10-K, which has been filed with the Securities
xkh341sz7f5hviuin 1tgu
AMH
18 Jun 24
Report on Form 10-K for the year ended December 31, 2023, and in the Company's
lwq44e4kjp47rojsvfhzpd8mdtx57 fjn4faiwwnjmkaocq8hu
BGS
18 Jun 24
Annual Report on Form 10-K and in its subsequent reports on Forms 10-Q and 8-K. Investors are cautioned not to place undue reliance on any such forward
utub7en1t1l5f2mpgp1dbycpmazlx1ci0d
EQC
18 Jun 24
"Risk Factors" in our most recent Annual Report on Form 10-K and subsequent quarterly reports on Form 10-Q
ttes4b66sldel950 xlldyxakyzg0tueskwnmoo528xgn
JBT
18 Jun 24
10-K filed with the U.S. Securities and Exchange Commission (the SEC) and in any subsequently filed Quarterly Reports on Form 10-Q. JBT cautions
531d14evkcn3fhwf5qe45l8vzr8bq8y5
TREE
18 Jun 24
" in the Company's Annual Report on Form 10-K, as may be amended from time to time by other reports the Company files with the SEC
euo86r7qa039p864b
MRCY
18 Jun 24
on Form 10-K for the fiscal year ended June 30, 2023 and subsequent Quarterly Reports on Form 10-Q and Current Reports on Form 8-K. The Company
unigtelt1d2u24x8ddng990153lj281w7t1z
IDEX
18 Jun 24
of Financial Condition and Results of Operations" in our most recent Form 10-K and Form 10-Q filed with the Securities and Exchange Commission, and similar